Equity Overview
Price & Market Data
Price: $5.97
Daily Change: -$0.547 / 9.16%
Daily Range: $5.60 - $6.44
Market Cap: $351,980,704
Daily Volume: 95,552
Performance Metrics
1 Week: -36.84%
1 Month: -40.96%
3 Months: -45.49%
6 Months: -21.87%
1 Year: -89.35%
YTD: -42.86%
Company Details
Employees: 16
Sector: Health technology
Industry: Biotechnology
Country:
Details
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.